Cargando…
The PET-derived tumor-to-blood standard uptake ratio (SUR) is superior to tumor SUV as a surrogate parameter of the metabolic rate of FDG
BACKGROUND: The standard uptake value (SUV) approach in oncological positron emission tomography has known shortcomings, all of which affect the reliability of the SUV as a surrogate of the targeted quantity, the metabolic rate of [(18)F]fluorodeoxyglucose (FDG), K(m). Among the shortcomings are tim...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4175513/ https://www.ncbi.nlm.nih.gov/pubmed/24267032 http://dx.doi.org/10.1186/2191-219X-3-77 |
Sumario: | BACKGROUND: The standard uptake value (SUV) approach in oncological positron emission tomography has known shortcomings, all of which affect the reliability of the SUV as a surrogate of the targeted quantity, the metabolic rate of [(18)F]fluorodeoxyglucose (FDG), K(m). Among the shortcomings are time dependence, susceptibility to errors in scanner and dose calibration, insufficient correlation between systemic distribution volume and body weight, and, consequentially, residual inter-study variability of the arterial input function (AIF) despite SUV normalization. Especially the latter turns out to be a crucial factor adversely affecting the correlation between SUV and K(m) and causing inter-study variations of tumor SUVs that do not reflect actual changes of the metabolic uptake rate. In this work, we propose to replace tumor SUV by the tumor-to-blood standard uptake ratio (SUR) in order to distinctly improve the linear correlation with K(m). METHODS: Assuming irreversible FDG kinetics, SUR can be expected to exhibit a much better linear correlation to K(m) than SUV. The theoretical derivation for this prediction is given and evaluated in a group of nine patients with liver metastases of colorectal cancer for which 15 fully dynamic investigations were available and K(m) could thus be derived from conventional Patlak analysis. RESULTS: For any fixed time point T at sufficiently late times post injection, the Patlak equation predicts a linear correlation between SUR and K(m) under the following assumptions: (1) approximate shape invariance (but arbitrary scale) of the AIF across scans/patients and (2) low variability of the apparent distribution volume V(r) (the intercept of the Patlak Plot). This prediction - and validity of the underlying assumptions - has been verified in the investigated patient group. Replacing tumor SUVs by SURs does improve the linear correlation of the respective parameter with K(m) from r = 0.61 to r = 0.98. CONCLUSIONS: SUR is an easily measurable parameter that is highly correlated to K(m). In this respect, it is clearly superior to SUV. Therefore, SUR should be seriously considered as a drop-in replacement for SUV-based approaches. |
---|